Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765604
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-03-10
Brief Title:
Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine Sf9 Cell WSK-V102
Sponsor:
Organization:
WestVac Biopharma Co Ltd